Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia

Patients with acute myeloid leukemia have a very poor prognosis related to a high rate of relapse and drug-related toxicity. The ability of leukemia stem cells (LSCs) to survive chemotherapy is primarily responsible for relapse, and eliminating LSCs is ultimately essential for cure. We developed nov...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nanomedicine
Main Authors: Lin, Tzu-yin, Zhu, Yanjun, Li, Yuanpei, Zhang, Hongyong, Ma, Ai-Hong, Long, Qilai, Keck, James, Lam, Kit S., Pan, Chong-xian, Jonas, Brian A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8237247/
https://ncbi.nlm.nih.gov/pubmed/31055076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2019.04.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados